ExecPay

Keith J. Kendall

Overview2021202020192018

Overview

Keith J. Kendall received an average of $3M in total compensation, including $523K in salary, at Aquestive Therapeutics from 2018 to 2021.

Source: SEC filings on April 29, 2022, May 5, 2021, and April 29, 2020.
Kendall's 2021 pay

Related executives

We found four more executives who work or worked at Aquestive Therapeutics.

Daniel Barber

Aquestive Therapeutics

Chief Executive Officer

6

Lori Braender

Aquestive Therapeutics

General Counsel

2

A Toth

Aquestive Therapeutics

Chief Financial Officer

2

John Maxwell

Aquestive Therapeutics

Chief Financial Officer

3

News

You may also like

Aquestive Therapeutics